immunity News and Research

RSS

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

A new study in the journal Clinical Infectious Diseases aimed to determine the relative vaccine effectiveness (rVE) in three different recipient cohorts, those who received the Ad26.COV2.S vaccine followed by Ad26.COV2.S booster, those who received the Ad26.COV2.S vaccine followed by an mRNA booster, and those who received two doses of an mRNA vaccine followed by an mRNA booster.

12 Feb 2023

Study identifies a previously unknown role of 'natural killer' immune cells

Melbourne researchers have improved our understanding of how the immune system is regulated to prevent disease, identifying a previously unknown role of 'natural killer' (NK) immune cells.

10 Feb 2023

Rockefeller scientists describe the genetics of severe SARS-CoV-2 infection in children

One of the most terrifying aspects of the COVID pandemic has been its unpredictably severe impact on some children.

10 Feb 2023

Is gut microbiome lipid metabolism a determinant of human health?

Researchers highlighted the role of lipids, especially bacteria-derived lipids in the gut microbiome, in mammalian physiology in the context of immunity and metabolism. Note that commensal fungal species also produce lipid metabolites.

10 Feb 2023

Casein-based diet found to protect diabetic mice against autoimmunity

Researchers studied diet-commensal microbial interactions in autoimmunity.

10 Feb 2023

Pegylated interferon lambda shows good efficacy against COVID-19

In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.

9 Feb 2023

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Two doses of mRNA covid-19 vaccine during pregnancy are highly effective against delta and moderately effective against omicron infection, and are linked to a lower risk of hospital admission in infants under six months of age, finds a Canadian study published by The BMJ today.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Researchers assess the impact of COVID-19 vaccination on immune responses during a breakthrough infection.

9 Feb 2023

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous vaccination improves the neutralization of SARS-CoV-2 Omicron sub-variants.

9 Feb 2023

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Biochemist Jon Jacobs has analyzed the blood of patients with diseases and conditions such as Ebola, cancer, tuberculosis, hepatitis, diabetes, Lyme disease, brain injury and influenza.

9 Feb 2023

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

A researchers emphasized the need to reconsider mRNA COVID-19 vaccination strategies in the future,

9 Feb 2023

Research reveals differences in the gut microbiomes of people with ME/CFS

The study was led by scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health, as part of the Center for Solutions for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

8 Feb 2023

Community engagement efforts in Alabama identify priority communities for SARS-CoV-2 testing

Researchers promote SARS-CoV-2 testing among underserved communities in rural Alabama.

8 Feb 2023

Study reveals how a subset of lung T regulatory cells protects against deadly pneumococcal disease

A new study by University of Liverpool researchers reveals how resistance to bacteraemic pneumonia is provided by a unique subset of lung T regulatory cells.

8 Feb 2023

Vaccination campaigns can reduce the impact of COVID-19 on pregnant women

Many African countries have no COVID-19 vaccination policy for pregnant women as a study in the BMJ Global Health journal shows pregnant women with COVID-19 are seven times more at risk of death.

8 Feb 2023

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Researchers discussed studies that explored T-cell immunity induced by SARS-CoV-2 infection and COVID-19 vaccination in cancer patients, individuals with HIV, and recipients of solid organ transplants.

8 Feb 2023

Could adhering to a healthy lifestyle decrease the risk of post–COVID-19 condition?

Researchers performed a prospective cohort study among 1981 female nurses to investigate whether maintaining a healthy lifestyle decreases the risk of post–coronavirus disease 2019 (COVID-19) condition (PCC) following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

8 Feb 2023

A waning outbreak of the mpox virus among men who have sex with men

In a recent study posted to the medRxiv* server, researchers developed a mathematical model to describe the mpox (Monkeypox) transmission among men who have sex with men (MSM). They used this model to understand how MSM behavioral changes shaped the mpox outbreak in the Netherlands in June/July 2022.

7 Feb 2023

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

In a recent study published in The New England Journal of Medicine, researchers reviewed selected acute-phase proteins concerning their production, structure, and function.

7 Feb 2023

immunity News and Research

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Study identifies a previously unknown role of 'natural killer' immune cells

Rockefeller scientists describe the genetics of severe SARS-CoV-2 infection in children

Is gut microbiome lipid metabolism a determinant of human health?

Casein-based diet found to protect diabetic mice against autoimmunity

Pegylated interferon lambda shows good efficacy against COVID-19

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Protein activity found to be more dysregulated in the blood of patients with alcohol-associated hepatitis

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

Research reveals differences in the gut microbiomes of people with ME/CFS

Community engagement efforts in Alabama identify priority communities for SARS-CoV-2 testing

Study reveals how a subset of lung T regulatory cells protects against deadly pneumococcal disease

Vaccination campaigns can reduce the impact of COVID-19 on pregnant women

Recent findings on T-cell immunity induced by SARS-CoV-2 infection and vaccination in immunocompromised individuals

Could adhering to a healthy lifestyle decrease the risk of post–COVID-19 condition?

A waning outbreak of the mpox virus among men who have sex with men

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News